| In EUR m | Q3 2021 | Q3 2020 | 9M 2021 | 9M 2020 |
| Revenue | 414.3 | 355.0 | 1,100.2 | 987.4 |
| EBITDA (adjusted) | 138.7 | 118.8 | 318.9 | 291.0 |
| Exceptional items | -2.5 | -5.2 | -5.6 | -20.5 |
| EBITDA | 136.1 | 113.6 | 313.3 | 270.5 |
| Amortization, depreciation and impairment losses | -75.2 | -83.4 | -230.1 | -253.7 |
| thereof attributable to purchase price allocations and impairment losses | -14.2 | -13.6 | -36.5 | -46.7 |
| EBIT | 60.9 | 30.2 | 83.2 | 16.9 |
| Net finance income/costs | -7.4 | -6.7 | -21.5 | -21.6 |
| EBT | 53.5 | 23.5 | 61.7 | -4.7 |
| Taxes | -13.0 | -3.4 | -15.1 | -0.8 |
| Consolidated profit or loss for the period | 40.4 | 20.1 | 46.6 | -5.5 |
| Adjusted consolidated profit or loss for the period | 56.2 | 35.7 | 83.4 | 54.1 |
| Free cash flow (before M&A transactions) | 76.7 | 55.5 | 159.4 | 144.9 |
| Net debt (Sep. 30 / Dec 31.) | 706.4 | 600.2 |
